TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Study of Positively Smoke Free on the Web (PSFW) for HIV-infected Smokers
Brief Summary: The purpose of this study is to evaluate the first web-based cessation program developed expressly for people living with HIV who smoke tobacco. Main study goals are (1) to evaluate the website's feasibility (i.e., recruitment, adherence, retention, and satisfaction) and (2) to complete a prospective, randomized controlled trial comparing the efficacy of the online program to standard care with a primary outcome of 3 month point-prevalence abstinence.


Options:
A: Arm Label: Web-Based Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Web-Based Tailored Smoking Cessation Intervention | Arm Label: Standard Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Web-Based Tailored Smoking Cessation Intervention, Behavioral: Standard of Care | Intervention Type: BEHAVIORAL; Name: Web-Based Tailored Smoking Cessation Intervention; Assigned to Arm(s): Standard Care, Web-Based Intervention | Intervention Type: BEHAVIORAL; Name: Standard of Care; Assigned to Arm(s): Standard Care
B: Arm Label: mHealth self-help + varenicline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline, Behavioral: Cognitive-behavioral self-help | Arm Label: mHealth MyMAP program + varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline, Behavioral: Cognitive-behavioral self-help, Behavioral: MyMAP (My Mobile Advice Program) | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): mHealth MyMAP program + varenicline, mHealth self-help + varenicline | Intervention Type: BEHAVIORAL; Name: Cognitive-behavioral self-help; Assigned to Arm(s): mHealth MyMAP program + varenicline, mHealth self-help + varenicline | Intervention Type: BEHAVIORAL; Name: MyMAP (My Mobile Advice Program); Assigned to Arm(s): mHealth MyMAP program + varenicline
C: Arm Label: Basic Internet; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Basic Internet | Arm Label: Enhanced Internet; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced Internet | Arm Label: Enhanced Internet plus Phone; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced Internet + phone | Intervention Type: BEHAVIORAL; Name: Basic Internet; Assigned to Arm(s): Basic Internet | Intervention Type: BEHAVIORAL; Name: Enhanced Internet; Assigned to Arm(s): Enhanced Internet | Intervention Type: BEHAVIORAL; Name: Enhanced Internet + phone; Assigned to Arm(s): Enhanced Internet plus Phone
D: Arm Label: Information Prescription; Type: EXPERIMENTAL; Interventions: Behavioral: Smoking Coach | Arm Label: QUIT-PRIMO; Type: EXPERIMENTAL; Interventions: Behavioral: Decide2Quit | Intervention Type: BEHAVIORAL; Name: Decide2Quit; Assigned to Arm(s): QUIT-PRIMO | Intervention Type: BEHAVIORAL; Name: Smoking Coach; Assigned to Arm(s): Information Prescription

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Study of Positively Smoke Free on the Web (PSFW) for HIV-infected Smokers
Brief Summary: The purpose of this study is to evaluate the first web-based cessation program developed expressly for people living with HIV who smoke tobacco. Main study goals are (1) to evaluate the website's feasibility (i.e., recruitment, adherence, retention, and satisfaction) and (2) to complete a prospective, randomized controlled trial comparing the efficacy of the online program to standard care with a primary outcome of 3 month point-prevalence abstinence.


Options:
A: Arm Label: Standard Care; Type: EXPERIMENTAL; Interventions: Behavioral: Standard Care | Arm Label: Motivational Enhancement; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Enhancement | Intervention Type: BEHAVIORAL; Name: Standard Care; Assigned to Arm(s): Standard Care | Intervention Type: BEHAVIORAL; Name: Motivational Enhancement; Assigned to Arm(s): Motivational Enhancement
B: Arm Label: Standard Care; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline | Arm Label: Standard Care + Text message; Type: EXPERIMENTAL; Interventions: Drug: Varenicline, Behavioral: Text Message | Arm Label: Standard Care + Text Message + ABT; Type: EXPERIMENTAL; Interventions: Drug: Varenicline, Behavioral: Text Message, Behavioral: Adherence Behavioral Therapy | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Standard Care, Standard Care + Text Message + ABT, Standard Care + Text message | Intervention Type: BEHAVIORAL; Name: Text Message; Assigned to Arm(s): Standard Care + Text Message + ABT, Standard Care + Text message | Intervention Type: BEHAVIORAL; Name: Adherence Behavioral Therapy; Assigned to Arm(s): Standard Care + Text Message + ABT
C: Arm Label: Web-Based Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Web-Based Tailored Smoking Cessation Intervention | Arm Label: Standard Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Web-Based Tailored Smoking Cessation Intervention, Behavioral: Standard of Care | Intervention Type: BEHAVIORAL; Name: Web-Based Tailored Smoking Cessation Intervention; Assigned to Arm(s): Standard Care, Web-Based Intervention | Intervention Type: BEHAVIORAL; Name: Standard of Care; Assigned to Arm(s): Standard Care
D: Arm Label: Hospital phone counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Telephone Counseling | Arm Label: Fax-to-quit; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Fax-to-quit | Intervention Type: BEHAVIORAL; Name: Telephone Counseling; Assigned to Arm(s): Hospital phone counseling | Intervention Type: BEHAVIORAL; Name: Fax-to-quit; Assigned to Arm(s): Fax-to-quit

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of the "Housing First Program" in Homeless Patients With Severe Mental Disorders in France: a Multicentric Randomized Controlled Study
Brief Summary: As mental health care shifted from state psychiatric hospitals to the community in France and western countries, the mental health system became inevitably involved in housing as it strove to meet the broader psychosocial needs of consumers. Simultaneously, as many consumers found themselves unable to find stable living in the community and struggling with addictions, they became a significant subgroup within a larger homeless population, which has received increasing policy attention over the past three decades. There are two distinct service models for adults who have severe mental illness and are homeless: the residential continuum model and the Housing First model.


Options:
A: Arm Label: Recovery management intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Recovery management | Intervention Type: BEHAVIORAL; Name: Recovery management; Assigned to Arm(s): Recovery management intervention
B: Arm Label: Extended-Release Naltrexone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Extended-Release Naltrexone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Extended-Release Naltrexone | Intervention Type: DRUG; Name: Extended-Release Naltrexone; Assigned to Arm(s): Extended-Release Naltrexone, Placebo
C: Arm Label: Motivational Interviewing; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing | Arm Label: Supervision As Usual; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Motivational Computer; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Computer | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): Motivational Interviewing | Intervention Type: BEHAVIORAL; Name: Motivational Computer; Assigned to Arm(s): Motivational Computer
D: Arm Label: Housing First Program; Type: EXPERIMENTAL; Interventions: Other: HOUSING FIRST PROGRAM | Arm Label: traditional French services; Type: ACTIVE_COMPARATOR; Interventions: Other: traditional French services | Intervention Type: OTHER; Name: HOUSING FIRST PROGRAM; Assigned to Arm(s): Housing First Program | Intervention Type: OTHER; Name: traditional French services; Assigned to Arm(s): traditional French services

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Renal Denervation in Patients With Resistant Hypertension
Brief Summary: The DENER-HTN study is a, multicenter, prospective, open, randomized, controlled study of the effectiveness and costs of renal denervation in addition to standardized medical treatment compared to medical treatment alone in subjects with resistant hypertension. Bilateral renal denervation will be performed using the Symplicity Catheter - a percutaneous system that delivers radiofrequency (RF) energy through the luminal surface of the renal artery.


Options:
A: Arm Label: Renal denervation; Type: EXPERIMENTAL; Interventions: Procedure: renal denervation and optimized medication regimen | Arm Label: optimized medication regimen; Type: OTHER; Interventions: Procedure: optimized medication regimen | Intervention Type: PROCEDURE; Name: renal denervation and optimized medication regimen; Assigned to Arm(s): Renal denervation | Intervention Type: PROCEDURE; Name: optimized medication regimen; Assigned to Arm(s): optimized medication regimen
B: Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Device: Boston Scientific Vessix Renal Denervation System | Arm Label: Control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Boston Scientific Vessix Renal Denervation System; Assigned to Arm(s): Intervention arm
C: Arm Label: Renal Denervation; Type: EXPERIMENTAL; Interventions: Device: Symplicity Spyral™ multi-electrode renal denervation system | Arm Label: Sham Procedure; Type: SHAM_COMPARATOR; Interventions: Procedure: Sham Procedure | Intervention Type: DEVICE; Name: Symplicity Spyral™ multi-electrode renal denervation system; Assigned to Arm(s): Renal Denervation | Intervention Type: PROCEDURE; Name: Sham Procedure; Assigned to Arm(s): Sham Procedure
D: Arm Label: Control group; Type: OTHER; Interventions: Procedure: Renal denervation | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Procedure: Renal denervation | Intervention Type: PROCEDURE; Name: Renal denervation; Assigned to Arm(s): Control group, Intervention group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Renal Denervation in Patients With Resistant Hypertension
Brief Summary: The DENER-HTN study is a, multicenter, prospective, open, randomized, controlled study of the effectiveness and costs of renal denervation in addition to standardized medical treatment compared to medical treatment alone in subjects with resistant hypertension. Bilateral renal denervation will be performed using the Symplicity Catheter - a percutaneous system that delivers radiofrequency (RF) energy through the luminal surface of the renal artery.


Options:
A: Arm Label: Renal sympathetic denervation; Type: EXPERIMENTAL; Interventions: Device: Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA) | Arm Label: Sham procedure; Type: SHAM_COMPARATOR; Interventions: Other: Sham procedure | Intervention Type: DEVICE; Name: Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA); Assigned to Arm(s): Renal sympathetic denervation | Intervention Type: OTHER; Name: Sham procedure; Assigned to Arm(s): Sham procedure
B: Arm Label: renal sympathetic denervation; Type: EXPERIMENTAL; Interventions: Procedure: renal sympathetic denervation, Drug: drug, Procedure: Direct-Current Cardioversion | Arm Label: drug therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: drug | Intervention Type: PROCEDURE; Name: renal sympathetic denervation; Assigned to Arm(s): renal sympathetic denervation | Intervention Type: DRUG; Name: drug; Assigned to Arm(s): drug therapy, renal sympathetic denervation | Intervention Type: PROCEDURE; Name: Direct-Current Cardioversion; Assigned to Arm(s): renal sympathetic denervation
C: Arm Label: Renal Denervation; Type: EXPERIMENTAL; Interventions: Device: Renal Denervation | Intervention Type: DEVICE; Name: Renal Denervation; Assigned to Arm(s): Renal Denervation
D: Arm Label: Renal denervation; Type: EXPERIMENTAL; Interventions: Procedure: renal denervation and optimized medication regimen | Arm Label: optimized medication regimen; Type: OTHER; Interventions: Procedure: optimized medication regimen | Intervention Type: PROCEDURE; Name: renal denervation and optimized medication regimen; Assigned to Arm(s): Renal denervation | Intervention Type: PROCEDURE; Name: optimized medication regimen; Assigned to Arm(s): optimized medication regimen

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Breakfast Omission on Postprandial Glycemia After Lunch and Dinner in T2D
Brief Summary: The investigators will explore the effect of omission of breakfast on postprandial hyperglycemia and insulin and intact GLP-1 response after subsequent meals in type 2 diabetic patients


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Alternate Day Fasting Arm; Type: OTHER; Interventions: Behavioral: calorie restriction | Arm Label: Calorie Restriction; Type: OTHER; Interventions: Behavioral: calorie restriction | Intervention Type: BEHAVIORAL; Name: calorie restriction; Assigned to Arm(s): Alternate Day Fasting Arm, Calorie Restriction
B: Arm Label: Weight Loss Phase; Type: EXPERIMENTAL; Interventions: Behavioral: Weight Loss Phase | Arm Label: Weight Loss Maintenance Phase; Type: EXPERIMENTAL; Interventions: Behavioral: HP-IF, Behavioral: HH | Intervention Type: BEHAVIORAL; Name: Weight Loss Phase; Assigned to Arm(s): Weight Loss Phase | Intervention Type: BEHAVIORAL; Name: HP-IF; Assigned to Arm(s): Weight Loss Maintenance Phase | Intervention Type: BEHAVIORAL; Name: HH; Assigned to Arm(s): Weight Loss Maintenance Phase
C: Arm Label: Calorie restriction (MACR); Type: EXPERIMENTAL; Interventions: Behavioral: Calorie restriction (MACR) | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Calorie restriction (MACR); Assigned to Arm(s): Calorie restriction (MACR)
D: Arm Label: Omitted Breakfast; Type: EXPERIMENTAL; Interventions: Other: Omitted Breakfast, Other: Breakfast | Arm Label: Breakfast; Type: ACTIVE_COMPARATOR; Interventions: Other: Omitted Breakfast, Other: Breakfast | Intervention Type: OTHER; Name: Omitted Breakfast; Assigned to Arm(s): Breakfast, Omitted Breakfast | Intervention Type: OTHER; Name: Breakfast; Assigned to Arm(s): Breakfast, Omitted Breakfast

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomised, Double-blind, Parallel-group, Active-comparator (Venlafaxine Extended Release), Fixed-dose Study of [Vortioxetine] Lu AA21004 in Major Depressive Disorder in Asian Countries
Brief Summary: This study will be conducted with the aim of investigating the efficacy, safety and tolerability of 10 mg/day Vortioxetine in Asian patients compared to an approved active comparator (venlafaxine extended release 150 mg/day).


Options:
A: Arm Label: Vortioxetine (Lu AA21004); Type: EXPERIMENTAL; Interventions: Drug: Vortioxetine (Lu AA21004) | Arm Label: Venlafaxine extended release; Type: ACTIVE_COMPARATOR; Interventions: Drug: Venlafaxine extended release | Intervention Type: DRUG; Name: Vortioxetine (Lu AA21004); Assigned to Arm(s): Vortioxetine (Lu AA21004) | Intervention Type: DRUG; Name: Venlafaxine extended release; Assigned to Arm(s): Venlafaxine extended release
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Vortioxetine (Lu AA21004) 5 mg; Type: EXPERIMENTAL; Interventions: Drug: Vortioxetine (Lu AA21004) | Arm Label: Vortioxetine (Lu AA21004) 10 mg; Type: EXPERIMENTAL; Interventions: Drug: Vortioxetine (Lu AA21004) | Arm Label: Venlafaxine XL 225 mg; Type: OTHER; Interventions: Drug: Venlafaxine XL | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Vortioxetine (Lu AA21004); Assigned to Arm(s): Vortioxetine (Lu AA21004) 10 mg, Vortioxetine (Lu AA21004) 5 mg | Intervention Type: DRUG; Name: Venlafaxine XL; Assigned to Arm(s): Venlafaxine XL 225 mg
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Vortioxetine 10 mg; Type: EXPERIMENTAL; Interventions: Drug: Vortioxetine (Lu AA21004) | Arm Label: Vortioxetine 20 mg; Type: EXPERIMENTAL; Interventions: Drug: Vortioxetine (Lu AA21004) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Vortioxetine (Lu AA21004); Assigned to Arm(s): Vortioxetine 10 mg | Intervention Type: DRUG; Name: Vortioxetine (Lu AA21004); Assigned to Arm(s): Vortioxetine 20 mg
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Vortioxetine 10 mg; Type: EXPERIMENTAL; Interventions: Drug: Vortioxetine | Arm Label: Vortioxetine 20 mg; Type: EXPERIMENTAL; Interventions: Drug: Vortioxetine | Intervention Type: DRUG; Name: Vortioxetine; Assigned to Arm(s): Vortioxetine 10 mg, Vortioxetine 20 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study of Community Based Dual Task and Aerobic Exercise Intervention on Cognition and Mobility in Older Adults Without Dementia
Brief Summary: The investigators proposed research will establish whether combining aerobic exercise with cognitive challenges is feasible and effective in community dwelling older adults with early signs of cognitive impairment.


Options:
A: Arm Label: Exercise Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise Intervention | Arm Label: Exercise Control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise Control | Intervention Type: BEHAVIORAL; Name: Exercise Intervention; Assigned to Arm(s): Exercise Intervention Group | Intervention Type: BEHAVIORAL; Name: Exercise Control; Assigned to Arm(s): Exercise Control group
B: Arm Label: Non-action video game training; Type: EXPERIMENTAL; Interventions: Behavioral: Experimental: Non-action video game training | Arm Label: Non-cognitive video game training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Comparator: Non-cognitive video game training | Intervention Type: BEHAVIORAL; Name: Experimental: Non-action video game training; Assigned to Arm(s): Non-action video game training | Intervention Type: BEHAVIORAL; Name: Active Comparator: Non-cognitive video game training; Assigned to Arm(s): Non-cognitive video game training
C: Arm Label: ThinkingFit; Type: EXPERIMENTAL; Interventions: Procedure: ThinkingFit programme | Intervention Type: PROCEDURE; Name: ThinkingFit programme; Assigned to Arm(s): ThinkingFit
D: Arm Label: Aerobic exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Group 1, Behavioral: Group 2 | Arm Label: Stretching/toning; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group 3, Behavioral: Group 4 | Arm Label: Computer-based mental activity training; Type: EXPERIMENTAL; Interventions: Behavioral: Group 1, Behavioral: Group 3 | Arm Label: Educational DVD training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group 2, Behavioral: Group 4 | Intervention Type: BEHAVIORAL; Name: Group 1; Assigned to Arm(s): Aerobic exercise, Computer-based mental activity training | Intervention Type: BEHAVIORAL; Name: Group 2; Assigned to Arm(s): Aerobic exercise, Educational DVD training | Intervention Type: BEHAVIORAL; Name: Group 3; Assigned to Arm(s): Computer-based mental activity training, Stretching/toning | Intervention Type: BEHAVIORAL; Name: Group 4; Assigned to Arm(s): Educational DVD training, Stretching/toning

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Behavioral Activation Therapy for Rural Veterans With Diabetes and Depression
Brief Summary: This clinical trial will compare the effectiveness of the Healthy Outcomes through Patient Empowerment (HOPE) intervention to enhanced usual care (EUC) for diabetes and depression at 6 and 12 month follow-up. The proposed study is a randomized controlled trial enrolling 242 largely rural Veterans with uncontrolled diabetes and clinically-significant depressive symptoms. Both groups will receive screening, education, and notification of clinical findings along with follow-up in usual primary care. HOPE participants will also receive behavioral coaching telephone sessions over a six month period. Patients in the control group will be screened, and providers will be notified of high risk patients' status and need for intervention. Both groups will receive only usual primary care during the subsequent 6 month maintenance period. Study measurements using self-report questionnaires will also be collected at baseline, 6 and 12 months follow-up. The investigators will also conduct chart reviews to evaluate usual care blood tests for diabetes control. Changes in measurements from baseline will be compared between groups. This intervention will reach Veterans in rural setting where community-based primary care is needed, especially care that blends treatment strategies for physical and emotional health.


Options:
A: Arm Label: Arm 1: HOPE; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Outcomes through Patient Empowerment (HOPE) | Arm Label: Arm 2: EUC; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Usual Care | Intervention Type: BEHAVIORAL; Name: Healthy Outcomes through Patient Empowerment (HOPE); Assigned to Arm(s): Arm 1: HOPE | Intervention Type: BEHAVIORAL; Name: Enhanced Usual Care; Assigned to Arm(s): Arm 2: EUC
B: Arm Label: Patient Navigator; Type: EXPERIMENTAL; Interventions: Other: Patient Navigator, Other: Usual care | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Patient Navigator; Assigned to Arm(s): Patient Navigator | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Patient Navigator
C: Arm Label: Self-management group workshops; Type: EXPERIMENTAL; Interventions: Behavioral: Self-management group workshops | Arm Label: No treament (wait-list control); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Self-management group workshops; Assigned to Arm(s): Self-management group workshops
D: Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: usual care | Arm Label: Standardized educational plan; Type: EXPERIMENTAL; Interventions: Other: Standardized educational plan | Intervention Type: OTHER; Name: Standardized educational plan; Assigned to Arm(s): Standardized educational plan | Intervention Type: OTHER; Name: usual care; Assigned to Arm(s): Usual care

Answer: A